Nls pharmaceutics ltd. and kadimastem ltd.

Zurich and ness ziona, israel , jan. 8, 2025 /prnewswire/ -- nls pharmaceutics ltd. ("nls") (nasdaq: nlsp), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous system disorders, and kadimastem ltd.
NLSP Ratings Summary
NLSP Quant Ranking